Illinois lawmakers continue to push for more regulatory control of pharmacy benefit managers, or PBMs. PBMs act as ...
The Department of Justice has filed an appeals court brief supporting the right of Medicare officials to negotiate ...
Lawyers for the government gave the first substantive signal that the Trump administration will continue to defend Medicare ...
The Trump administration is moving forward with the defense of a Biden-era plan that allows Medicare to negotiate drug prices ...
His proposal could prevent pharmacy benefit managers from inflating medication costs by banning spread pricing.
Pharmacy benefits managers, or PBMs, are meant to act as a middleman between drug manufacturers and insurance companies to ...
China’s share of the global drug development pipeline grew from 3% in 2013 to 28% in 2023, positioning China as the second-largest region for clinical trials after the United States. Additionally, the ...
As the second Trump administration settles in, the U.S.' top pharmaceutical trade group is drafting its ambitions for the ...
U.S. President Donald Trump will meet on Thursday with chief executives from major drugmakers, a White House official ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback